1. Introduction
inflammatory bowel disease of the colonic mucosa, Ulcerative colitis, UC
ULCERATIVE COLITIS
Ulcerative colitis [UC] is an inflammatory bowel disease of the colonic mucosa that negatively affects patients’ health-related quality of life [HRQoL].Patients consider the ability to improve HRQoL to be among the most important attributes of a UC treatment.Filgotinib is an oral Janus kinase [JAK] 1 preferential inhibitor that has been approved in the European Union and the UK for the treatment of adults with moderately to severely active UC.In these exploratory and 